Estrogen receptors in colorectal cancer: Goalkeepers, strikers, or bystanders?

Cancer Prevention Research

Volumn 3, Issue 8, 2010, Pages 897-899

  Hartman, Johan ^a   Gustafsson, Jan Åke ^b,c  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c University of Houston   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; PHYTOESTROGEN;

CANCER PREVENTION; CANCER RISK; COLON CARCINOGENESIS; COLORECTAL CANCER; DRUG RESEARCH; HUMAN; NONHUMAN; PHYTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW;

ANIMALS; CARCINOMA; COLORECTAL NEOPLASMS; DISEASE PROGRESSION; FEMALE; HUMANS; MICE; RECEPTORS, ESTROGEN; SIGNAL TRANSDUCTION;

EID: 77955433881     PISSN: 19406207     EISSN: 19406215     Source Type: Journal    
DOI: 10.1158/1940-6207.CAPR-10-0132     Document Type: Review

References (28)

1. Potter JD. Nutrition and colorectal cancer. Cancer Causes Control 1996;7:127-46.
2. Cross AJ, Leitzmann MF, Gail MH, Hollenbeck AR, Schatzkin A, Sinha R. A prospective study of red and processed meat intake in relation to cancer risk. PLoS Med 2007;4:e325.
3. Marques-Vidal P, Ravasco P, Ermelinda Camilo M. Foodstuffs and colorectal cancer risk: a review. Clin Nutr 2006;25:14-36.
4. Alexander DD, Cushing CA, Lowe KA, Sceurman B, Roberts MA. Meta-analysis of animal fat or animal protein intake and colorectal cancer. Am J Clin Nutr 2009;89:1402-9.
5. Koushik A, Hunter DJ, Spiegelman D, et al. Fruits, vegetables, and colon cancer risk in a pooled analysis of 14 cohort studies. J Natl Cancer Inst 2007;99:1471-83.
6. Chlebowski RT, Wactawski-Wende J, Ritenbaugh C, et al. Estrogen plus progestin and colorectal cancer in postmenopausal women. N Engl J Med 2004;350:991-1004.
7. DeCosse JJ, Ngoi SS, Jacobson JS, Cennerazzo WJ. Gender and colorectal cancer. Eur J Cancer Prev 1993;2:105-15.
8. Ries LA, Wingo PA, Miller DS, et al. The annual report to the nation on the status of cancer, 1973-1997, with a special section on colorectal cancer. Cancer 2000;88:2398-424.
9. Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002;288:321-33.
10. Modena MG, Sismondi P, Mueck AO, et al. New evidence regarding hormone replacement therapies is urgently required: transdermal postmenopausal hormone therapy differs from oral hormone therapy in risks and benefits. Maturitas 2005;52:1-10.
11. Fernandez E, La Vecchia C, Balducci A, Chatenoud L, Franceschi S, Negri E. Oral contraceptives and colorectal cancer risk: a metaanalysis. Br J Cancer 2001;84:722-7.
12. Jin P, Lu X-J, Sheng J-Q, et al. Estrogen stimulates the expression of mismatch repair gene hMLH1 in colonic epithelial cells. Cancer Prev Res 2010;3:910-6.
13. Kushner PJ, Agard DA, Greene GL, et al. Estrogen receptor pathways to AP-1. J Steroid Biochem Mol Biol 2000;74:311-7.
14. Saville B, Wormke M, Wang F, et al. Ligand-, cell-, and estrogen receptor subtype (α/β)-dependent activation at GC-rich (Sp1) promoter elements. J Biol Chem 2000;275:5379-87.
15. Heldring N, Pike A, Andersson S, et al. Estrogen receptors: how do they signal and what are their targets. Physiol Rev 2007;87:905-31.
16. Waliszewski P, Blaszczyk M, Wolinska-Witort E, Drews M, Snochowski M, Hurst RE. Molecular study of sex steroid receptor gene expression in human colon and in colorectal carcinomas. J Surg Oncol 1997;64:3-11.
17. Castiglione F, Taddei A, Degl'Innocenti DR, et al. Expression of estrogen receptor β in colon cancer progression. Diagn Mol Pathol 2008;17:231-6.
18. Hartman J, Lindberg K, Morani A, Inzunza J, Strom A, Gustafsson JA. Estrogen receptor β inhibits angiogenesis and growth of T47D breast cancer xenografts. Cancer Res 2006;66:11207-13.
19. Hartman J, Strom A, Gustafsson JA. Estrogen receptor β in breast cancer-diagnostic and therapeutic implications. Steroids 2009;74:635-41.
20. Strom A, Hartman J, Foster JS, Kietz S, Wimalasena J, Gustafsson JA. Estrogen receptor β inhibits 17β-estradiol-stimulated proliferation of the breast cancer cell line T47D. Proc Natl Acad Sci U S A 2004;101:1566-71.
21. Stefanick ML, Anderson GL, Margolis KL, et al. Effects of conjugated equine estrogens on breast cancer and mammography screening in postmenopausalwomenwith hysterectomy. JAMA2006;295:1647-57.
22. Hartman J, Edvardsson K, Lindberg K, et al. Tumor repressive functions of estrogen receptor β in SW480 colon cancer cells. Cancer Res 2009;69:6100-6.
23. Early Breast Cancer Trialists' Collaborative Group. Tamoxifen for early breast cancer: an overview of the randomised trials. Lancet 1998;351:1451-67.
24. Curtis RE, Boice JD, Jr., Shriner DA, Hankey BF, Fraumeni JF, Jr. Second cancers after adjuvant tamoxifen therapy for breast cancer. J Natl Cancer Inst 1996;88:832-4.
25. Cook LS, Weiss NS, Pharris-Ciurej N, Schwartz SM, White E. Colorectal cancer following tamoxifen therapy for breast cancer (United States). Cancer Causes Control 2001;12:405-10.
26. Lathers CM. Endocrine disruptors: a new scientific role for clinical pharmacologists? Impact on human health, wildlife, and the environment. J Clin Pharmacol 2002;42:7-23.
27. Barone M, Tanzi S, Lofano K, et al. Dietary-induced ERβ upregulation counteracts intestinal neoplasia development in intact male ApcMin/+ mice. Carcinogenesis 2010;31:269-74.
28. Raju J, Bielecki A, Caldwell D, et al. Soy isoflavones modulate azoxymethane-induced rat colon carcinogenesis exposed pre- and postnatally and inhibit growth of DLD-1 human colon adenocarcinoma cells by increasing the expression of estrogen receptor-β. J Nutr 2009;139:474-81.